Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Forschungzentrum Borstel Leibniz-Lungenzentrum maintains 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is handled by 1 distinct examiner, GOUGH, TIFFANY MAUREEN, within 1 distinct art unit. GOUGH, TIFFANY MAUREEN is the busiest examiner with 1 pending action, covering the company's entire active prosecution. This biotech portfolio currently proceeds through a single examination channel, which simplifies the management of the company's intellectual property assets.
With only 1 pending office action active, the applicant can dedicate significant attention to the specific requirements of the 1 distinct art unit involved. The role of GOUGH, TIFFANY MAUREEN as the 1 distinct examiner means that her individual interpretation of pharmaceutical claims will be the primary factor in the case's outcome. Practitioners should focus on aligning their technical disclosures with the specific expectations of this 1 distinct art unit to facilitate a smooth prosecution process for this single biotechnology matter.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GOUGH, TIFFANY MAUREEN | 1 | 31.7% | +46.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18041606 | METHOD FOR DETERMINATION OF BASOPHIL ACTIVATION AND KITS THEREFORE | GOUGH, TIFFANY MAUREEN | 28d overdue |
| Art Unit | Apps |
|---|---|
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18041606 | METHOD FOR DETERMINATION OF BASOPHIL ACTIVATION AND KITS THEREFORE | GOUGH, TIFFANY MAUREEN | 1651 | §103Other | Final Rejection | 28d overdue | Pending | Feb 14, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialForschungzentrum Borstel Leibniz-Lungenzentrum has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Tiffany Maureen Gough has the most, with 1 of Forschungzentrum Borstel Leibniz-Lungenzentrum's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
